Wang et al. have also reported this protein’s novel function in transcriptionally modulating p21 expression through a p53-independent mechanism, with a resulting impact on the G0/G1 phase cell cycle arrest in bladder cancer [58]. The gene discussed is TP53; the disease is urinary bladder carcinoma.